P. N. Aranguren

Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay.

Juan F. García, R. Bengió, M. Pavlovsky, 2011, Clinical lymphoma, myeloma & leukemia.

Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.

C. Corrado, A. Rosso, E. Raslawski, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biphenotypic Acute Leukemia with t(15;17)

M. Giunta, J. Sanjurjo, P. Aranguren, 2005, Leukemia & lymphoma.

Amplification of the BCR/ABL fusion gene clustered on a masked Philadelphia chromosome in a patient with myeloblastic crisis of chronic myelocytic leukemia.

I. Larripa, P. Gargallo, M. T. Cuello, 2003, Cancer genetics and cytogenetics.

PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients

M. M. Mela Osorio, L. Ferrari, M. Moirano, 2023, Annals of Hematology.

Partial and total monosomal karyotypes in myelodysplastic syndromes: Comparative prognostic relevance among 421 patients

R. Bengió, I. Larripa, J. Arbelbide, 2011, American journal of hematology.